Schroder Investment Management Group Has $259.06 Million Stake in HCA Healthcare, Inc. $HCA

Schroder Investment Management Group raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 1.9% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 676,225 shares of the company’s stock after purchasing an additional 12,515 shares during the period. Schroder Investment Management Group’s holdings in HCA Healthcare were worth $259,062,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $1,021,000. LPL Financial LLC boosted its position in shares of HCA Healthcare by 6.3% during the 1st quarter. LPL Financial LLC now owns 65,463 shares of the company’s stock worth $22,621,000 after acquiring an additional 3,882 shares in the last quarter. Arkadios Wealth Advisors raised its position in HCA Healthcare by 1.3% during the first quarter. Arkadios Wealth Advisors now owns 3,480 shares of the company’s stock valued at $1,202,000 after purchasing an additional 45 shares in the last quarter. NorthRock Partners LLC increased its stake in shares of HCA Healthcare by 7.1% in the 1st quarter. NorthRock Partners LLC now owns 2,145 shares of the company’s stock valued at $741,000 after purchasing an additional 143 shares during the last quarter. Finally, Natixis Advisors LLC boosted its stake in HCA Healthcare by 6.5% in the first quarter. Natixis Advisors LLC now owns 114,123 shares of the company’s stock valued at $39,435,000 after buying an additional 6,921 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $512.94 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00. The firm has a 50 day moving average price of $452.07 and a two-hundred day moving average price of $406.12. The firm has a market cap of $117.05 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the previous year, the business earned $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, October 27th. KeyCorp boosted their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. UBS Group upped their target price on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Finally, TD Cowen raised their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $474.53.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.